Clinical Trial Update: Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating MDMA-assisted therapy for PTSD and moral injury in veterans is currently recruiting. The trial is sponsored by Herzog Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Herzog Hospital | Conditions: PTSD, Post Traumatic Stress Disorder, Moral Injury | Phase 3 | Status: RECRUITING